Market Overview:
Semaglutide is a GLP-1 receptor agonist used for glycemic control in adults with type 2 diabetes and for chronic weight management in adults with obesity or overweight and at least one weight-related comorbidity. Semaglutide helps in reducing appetite, decreasing food consumption and slowing down digestion. It plays a vital role in controlling blood sugar levels and managing obesity by inducing weight loss.
Semaglutide is a type of GLP-1 receptor agonist used for the treatment of type 2 diabetes and obesity. It mimics the effects of naturally occurring hormone called GLP-1, which helps in maintaining normal blood sugar levels through various modes of action like increasing insulin production and decreasing the release of sugar into the bloodstream from the liver. The growing prevalence of diabetes and obesity worldwide is driving the demand for semaglutide which offer effective treatment ... Read more
